WO1998015830A3 - Homogenous luminescence energy transfer assays - Google Patents

Homogenous luminescence energy transfer assays Download PDF

Info

Publication number
WO1998015830A3
WO1998015830A3 PCT/FI1997/000560 FI9700560W WO9815830A3 WO 1998015830 A3 WO1998015830 A3 WO 1998015830A3 FI 9700560 W FI9700560 W FI 9700560W WO 9815830 A3 WO9815830 A3 WO 9815830A3
Authority
WO
WIPO (PCT)
Prior art keywords
energy
energy transfer
assays
luminescence energy
transfer assays
Prior art date
Application number
PCT/FI1997/000560
Other languages
French (fr)
Other versions
WO1998015830A2 (en
Inventor
Ilkka Antero Hemmilae
Pertti Juhani Hurskainen
Kaj Runar Blomberg
Veli-Matti Mukkala
Harri Juha Takalo
Satu Anneli Kovanen
Stuart Alan Webb
Original Assignee
Wallac Oy
Ilkka Antero Hemmilae
Pertti Juhani Hurskainen
Kaj Runar Blomberg
Veli-Matti Mukkala
Harri Juha Takalo
Satu Anneli Kovanen
Stuart Alan Webb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallac Oy, Ilkka Antero Hemmilae, Pertti Juhani Hurskainen, Kaj Runar Blomberg, Veli-Matti Mukkala, Harri Juha Takalo, Satu Anneli Kovanen, Stuart Alan Webb filed Critical Wallac Oy
Priority to JP10517208A priority Critical patent/JP2001502055A/en
Priority to EP97919087A priority patent/EP0929810A2/en
Publication of WO1998015830A2 publication Critical patent/WO1998015830A2/en
Publication of WO1998015830A3 publication Critical patent/WO1998015830A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6408—Fluorescence; Phosphorescence with measurement of decay time, time resolved fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G01N2021/6441—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/40—Rare earth chelates

Abstract

The invention relates to improvements of energy-transfer based homogeneous assays, which use time-resolved fluorometry in detection. The specific improvements relate to the type of lanthanide chelate labels used as energy donors, optimized energy acceptors for defined assays, the way energy transfer is measured using optimized filters and time windows, ways to correct all possible interferences derived from samples, use the assay for multi-component analysis and development of simplified assay protocols.
PCT/FI1997/000560 1996-10-04 1997-09-19 Homogenous luminescence energy transfer assays WO1998015830A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP10517208A JP2001502055A (en) 1996-10-04 1997-09-19 Homogeneous luminescence energy transfer assay
EP97919087A EP0929810A2 (en) 1996-10-04 1997-09-19 Homogenous luminescence energy transfer assays

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI963989 1996-10-04
FI963989A FI963989A (en) 1996-10-04 1996-10-04 Homogeneous methods of determination based on the transmission of luminescence energy

Publications (2)

Publication Number Publication Date
WO1998015830A2 WO1998015830A2 (en) 1998-04-16
WO1998015830A3 true WO1998015830A3 (en) 1998-06-18

Family

ID=8546810

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FI1997/000560 WO1998015830A2 (en) 1996-10-04 1997-09-19 Homogenous luminescence energy transfer assays

Country Status (4)

Country Link
EP (1) EP0929810A2 (en)
JP (1) JP2001502055A (en)
FI (1) FI963989A (en)
WO (1) WO1998015830A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9110075B2 (en) 2001-05-21 2015-08-18 Monogram Biosciences, Inc. Compositions for analyzing proteins

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998146A (en) * 1998-07-17 1999-12-07 Wallac Oy Homogeneous luminescence assay method based on energy transfer
WO2000039335A1 (en) * 1998-12-24 2000-07-06 Aclara Biosciences, Inc. Individually addressable solid surfaces for multiplexed operations
FR2792072A1 (en) * 1999-04-08 2000-10-13 Cis Bio Int HOMOGENEOUS METHOD OF DETECTING OR DETERMINING A CHEMICAL OR PHYSICOCHEMICAL INTERACTION
WO2001040805A1 (en) * 1999-11-30 2001-06-07 Akzo Nobel N.V. Steroid compounds for steroid receptor binding assays
JP2001255326A (en) * 2000-01-31 2001-09-21 Pen State Res Found:The Inquiry related to change of content in hermetically sealed container
FI20000333A0 (en) 2000-02-16 2000-02-16 Jussi Nurmi A homogeneous method for detecting a polynucleotide
US7771929B2 (en) 2000-04-28 2010-08-10 Monogram Biosciences, Inc. Tag library compounds, compositions, kits and methods of use
US7160735B2 (en) 2000-04-28 2007-01-09 Monogram Biosciences, Inc. Tagged microparticle compositions and methods
FR2809817B1 (en) * 2000-06-02 2003-08-15 Cis Bio Int METHOD FOR DETECTING THE PRESENCE OF A LIQUID IN A MIXTURE
DE10058596A1 (en) 2000-11-25 2002-06-06 Aventis Pharma Gmbh Method of screening chemical compounds for modulating the interaction of an EVH1 domain or a protein with an EVH1 domain with an EVH1 binding domain or a protein with an EVH1 binding domain, and a method for detecting said interaction
WO2002088733A1 (en) 2001-04-23 2002-11-07 Eiken Kagaku Kabushiki Kaisha Analysis method using reporter (label) intermolecular interaction
WO2002094998A2 (en) 2001-05-21 2002-11-28 Aclara Biosciences, Inc. Analyzing phosphorylated proteins
US7358052B2 (en) 2001-05-26 2008-04-15 Monogram Biosciences, Inc. Catalytic amplification of multiplexed assay signals
US7211440B2 (en) 2002-03-08 2007-05-01 Wallac Oy Dissociative fluorescence enhancement assay
US20040229294A1 (en) 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB surface receptor complexes as biomarkers
JP4206378B2 (en) 2002-07-08 2009-01-07 哲雄 長野 Fluorescent probe
US7696245B2 (en) 2003-03-28 2010-04-13 Sekisui Medical Co., Ltd. Fluorescent probe for zinc
FI20030460A0 (en) 2003-03-28 2003-03-28 Tero Soukka Homogeneous method of determination based on transmission of luminescence energy
DE602004008243T2 (en) * 2003-03-28 2008-05-15 Tero Soukka Homogeneous bioassay method based on luminescence energy transfer
CN1886661B (en) * 2003-10-01 2010-06-02 沃拉克有限公司 Improved homogeneous time-resolved energy transfer assay
WO2005062048A1 (en) 2003-12-01 2005-07-07 Dade Behring Marburg Gmbh Homogeneous detection method
JP2005194244A (en) 2004-01-09 2005-07-21 Shigenobu Yano Zinc ion fluorescence sensor
GB2433993B (en) * 2004-10-19 2010-04-28 Wallac Oy Single molecule TR-FRET probe
US20060115842A1 (en) * 2004-10-22 2006-06-01 Wallac Oy Highly sensitive homogeneous assay based on anti-Stokes' shift FRET measurement
US20090298196A1 (en) * 2005-01-28 2009-12-03 Uwabe Ken-Ichiro Quantitative measurement method for recombinant protein
US7826052B2 (en) 2005-05-24 2010-11-02 Hidex Oy Correction method and measurement device for anti-stokes photoluminescence measurement
EP1994407A4 (en) 2005-12-30 2009-05-20 Turun Yliopisto Method for determination of concentration, charge or unit size of a substance
WO2007125822A1 (en) * 2006-04-28 2007-11-08 Tokyo Institute Of Technology Complex for use in the screening of substance
EP1933151A1 (en) 2006-12-15 2008-06-18 F. Hoffmann-La Roche Ag Assays for measuring phosphate modification enzyme activity
EP2053059A1 (en) 2007-10-26 2009-04-29 Sanofi-Aventis Complexes of TRPC domains and SESTD1 domains and methods and uses involving the same
BRPI0922820A2 (en) 2008-12-04 2015-12-22 Sanofi Sa methods and uses involving heme-binding protein 1
EP2226633A1 (en) 2009-03-06 2010-09-08 Charité - Universitätsmedizin Berlin Uses and methods for the identification of a cytoprotective compound involving gp130 or LIFRalpha
CA2759885A1 (en) * 2009-04-30 2010-11-04 Etienne Doumazane Method for detecting compounds modulating dimers of vft domain membrane proteins
EP2267152A1 (en) 2009-06-26 2010-12-29 Sanofi-Aventis Test system for measuring MEST activity as well as methods and uses involving the same
EP2320236A1 (en) 2009-11-06 2011-05-11 Sanofi-aventis Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2348130A1 (en) 2010-01-21 2011-07-27 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2348129A1 (en) 2010-01-21 2011-07-27 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2348128A1 (en) 2010-01-21 2011-07-27 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
WO2011113891A1 (en) 2010-03-18 2011-09-22 Sanofi-Aventis Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
WO2011113888A1 (en) 2010-03-18 2011-09-22 Sanofi-Aventis Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
US8673823B2 (en) 2010-03-18 2014-03-18 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2390348A1 (en) 2010-05-25 2011-11-30 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2390349A1 (en) 2010-05-25 2011-11-30 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
EP2532755A1 (en) 2011-06-10 2012-12-12 Sanofi-Aventis Methods and uses based on Slfn2 expression and relating to the identification and profiling of compounds for use in the treatment or prevention of pain
CN102353790B (en) * 2011-06-25 2014-03-05 南方医科大学 Homogeneous time-resolved fluorescence analysis method of alpha-fetalprotein
WO2013188927A1 (en) 2012-06-22 2013-12-27 Macquarie University Multiplex suspension assay/array using lifetime coding
EP2986737A1 (en) 2013-04-15 2016-02-24 Wallac OY A method and a device for cross-talk correction of measured intensities
CN104181310A (en) * 2014-07-30 2014-12-03 美艾利尔（上海）诊断产品有限公司 Time resolution immunity fluorescence kit for detecting content of beta-hCG as well as preparation method and application thereof
JP2020533595A (en) 2017-09-13 2020-11-19 プロジェニティ， インコーポレイテッド Pre-eclampsia biomarkers and related systems and methods
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Assessment of preeclampsia using assays for free and dissociated placental growth factor
FI130554B (en) 2020-01-20 2023-11-16 Oy Arctic Partners Ab Luminescence hybridisation assay method

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007955A1 (en) * 1986-06-17 1987-12-30 Baxter Travenol Laboratories, Inc. Homogeneous fluoroassay methods employing fluorescent background rejection and water-soluble rare earth metal chelate fluorophores
US4868103A (en) * 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
GB2223096A (en) * 1988-09-06 1990-03-28 Atomic Energy Authority Uk Detecting a selected species
US4996143A (en) * 1985-12-23 1991-02-26 Syngene, Inc. Fluorescent stokes shift probes for polynucleotide hybridization
WO1992001224A1 (en) * 1990-07-13 1992-01-23 Cis Bio International Method for reducing interference in a fluorescent assay
US5194300A (en) * 1987-07-15 1993-03-16 Cheung Sau W Methods of making fluorescent microspheres
US5326692A (en) * 1992-05-13 1994-07-05 Molecular Probes, Inc. Fluorescent microparticles with controllable enhanced stokes shift
EP0649020A1 (en) * 1993-10-13 1995-04-19 Wallac Oy Luminescent lanthanide chelates with decreased non-radiative energy loss
WO1996000901A1 (en) * 1994-06-29 1996-01-11 The Regents Of The University Of California Luminescent lanthanide chelates and methods of use
FI96367B (en) * 1994-10-17 1996-02-29 Erkki Juhani Soini Biospecific determination method
US5512493A (en) * 1990-07-13 1996-04-30 Cis Bio International Method of amplifying the emission signal of a luminescent compound
WO1996030540A2 (en) * 1995-03-20 1996-10-03 The Regents Of The University Of California Substrates for beta-lactamase and uses thereof

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996143A (en) * 1985-12-23 1991-02-26 Syngene, Inc. Fluorescent stokes shift probes for polynucleotide hybridization
US4868103A (en) * 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
WO1987007955A1 (en) * 1986-06-17 1987-12-30 Baxter Travenol Laboratories, Inc. Homogeneous fluoroassay methods employing fluorescent background rejection and water-soluble rare earth metal chelate fluorophores
US5194300A (en) * 1987-07-15 1993-03-16 Cheung Sau W Methods of making fluorescent microspheres
GB2223096A (en) * 1988-09-06 1990-03-28 Atomic Energy Authority Uk Detecting a selected species
US5512493A (en) * 1990-07-13 1996-04-30 Cis Bio International Method of amplifying the emission signal of a luminescent compound
WO1992001224A1 (en) * 1990-07-13 1992-01-23 Cis Bio International Method for reducing interference in a fluorescent assay
US5326692A (en) * 1992-05-13 1994-07-05 Molecular Probes, Inc. Fluorescent microparticles with controllable enhanced stokes shift
US5326692B1 (en) * 1992-05-13 1996-04-30 Molecular Probes Inc Fluorescent microparticles with controllable enhanced stokes shift
EP0649020A1 (en) * 1993-10-13 1995-04-19 Wallac Oy Luminescent lanthanide chelates with decreased non-radiative energy loss
WO1996000901A1 (en) * 1994-06-29 1996-01-11 The Regents Of The University Of California Luminescent lanthanide chelates and methods of use
FI96367B (en) * 1994-10-17 1996-02-29 Erkki Juhani Soini Biospecific determination method
WO1996030540A2 (en) * 1995-03-20 1996-10-03 The Regents Of The University Of California Substrates for beta-lactamase and uses thereof

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
ANALYTICAL BIOCHEMISTRY, Volume 218, 1994, PENGGUANG WU et al., "Resonance Energy Transfer: Methods and Applications", pp. 1-13. *
BIOCONJUGATE CHEMISTRY, Volume 6, No. 3, 1995, HEIKKI MIKOLA et al., "Syntheses and Properties of Luminescent Lanthanide Chelate Labels and Labeled Haptenic Antigens for Homogeneous Immunoassays", pages 239-240. *
CHEMICAL ABSTRACTS, Volume 125, No. 15, 7 Sept. 1996, (Columbus, Ohio, USA), GOTHOT ANDRE et al., "A Strategy for Multiple Immunophenotyping by Image Cytometry: Model Studies Using Latex Microbeads Labeled with Seven Streptavidin-Bound Fluorochromes", page 1, Abstract No. 189844; & CYTOMETRY, 1996, 24(3), 214-225. *
CLIN. CHEM., Volume 39/9, 1993, GERARD MATHIS, "Rare Earth Cryptates and Homogeneous Fluoroimmunoassays with Human Sera", pages 1953-1959. *
CLINICAL CHEMISTRY, Volume 41, No. 9, 1995, GERARD MATHIS, "Probing Molecular Interactions with Homogeneous Techniques Based on Rare Earth Cryptates and Fluorescence Energy Transfer", pages 1391-1397. *
CYTOMETRY, Volume 19, 1995, JANOS MATKO et al., "Luminescence Quenching by Long Range Electron Transfer: A Probe of Protein Clustering and Conformation at the Cell Surface", pages 191-200. *
DIALOG INFORMATION SERVICE, File 154, Medline, Dialog Accession No. 08019516, Medline Accession No. 95009192, CONDRAU M.A. et al., "Time-Resolved Flow Cytometry for the Measurement of Lanthanide Chelate Fluorescence: I. Concept and Theoretical Evaluation"; & CYTOMETRY, (UNITED STATES), 1 Jul. 1994, 16(3), p187-194. *
DIALOG INFORMATION SERVICE, File 154, Medline, Dialog Accession No. 08019517, Medline Accession No. 95009193, CONDRAU M.A. et al., "Time-Resolved Flow Cytometry for the Measurement of Lanthanide Chelate Fluorescence: II. Instrument Design and Experimental Results"; & CYTOMETRY, (UNITED STATES), 1 Jul. 1994, 16(3), p195-205. *
JOURNAL OF ALLOYS AND COMPOUNDS, Volume 249, 1997, ILKKA HEMMILA et al., "Development of Luminescent Lanthanide Chelate Labels for Diagnostic Assays", pages 158-162. *
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B: BIOLOGY, Volume 27, 1995, EVA F. GUDGIN DICKSON et al., "New Trends in Photobiology (Invited Reviews), Time-Resolved Detection of Lanthanide Luminescence for Ultrasensitive Bioanalytical Assays", pages 3-19. *
METH. ENZYNIOL., Volume 246, 1995, PAUL R. SELVIN, "Fluorescence Resonance Energy Transfer", pages 300-335. *
PROC. NATL. ACAD. SCI. U.S.A., Vol. 91, October 1994, PAUL R. SELVIN et al., "Luminescence Energy Transfer Using a Terbium Chelate: Improvements on Fluorescence Energy Transfer", pages 10024-10028. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9110075B2 (en) 2001-05-21 2015-08-18 Monogram Biosciences, Inc. Compositions for analyzing proteins

Also Published As

Publication number Publication date
FI963989A (en) 1998-04-05
FI963989A0 (en) 1996-10-04
EP0929810A2 (en) 1999-07-21
JP2001502055A (en) 2001-02-13
WO1998015830A2 (en) 1998-04-16

Similar Documents

Publication Publication Date Title
WO1998015830A3 (en) Homogenous luminescence energy transfer assays
AU6702398A (en) Fluorescent protein sensors for detection of analytes
WO2001038873A3 (en) Devices and methods for detecting analytes using electrosensor having capture reagent
EP0957365A4 (en) Fluorescence polarization method
DE69527361T2 (en) COLOR COUPLER FOR SPECTROPHOTOMETRIC DETERMINATION OF ANALYZES
MX9606509A (en) Stable coupling dye for photometric determination of analytes cross-reference to related application.
WO2002084266A3 (en) Biological measurement system
AU9066998A (en) Use of check surfaces for identifying disturbing samples in a detection procedure
EP0915173A3 (en) Kit and method for fluorescence based detection assay
AU6779698A (en) Agglutrimetric assays in blood
AU582293B2 (en) Heterogeneous specific binding assay employing an aggregatable binding reagent
WO2007001737A3 (en) Methods and compositions for detecting herpes simplex virus type 2
ES2095310T3 (en) REAGENT FEED CONTROL PROCEDURE IN A SWEEPING SPECTROPHOTOMETER.
WO2002054045A3 (en) Reagent for luminescence optical determination of an analyte
DE69430539D1 (en) PRIMERS FOR GENAMPLIFICATING ENTEROTOXIN AND LECITHINASE FROM CLOSTRIDIUM PERFRINGENS AND THEIR APPLICATION FOR DETECTING AND COUNTING THESE BACTERIA
DK314987A (en) PROCEDURE FOR SPECIFIC DETERMINATION OF SERUM FRUCTOSAMINE CONTENT AND ITS SUITABLE REAGENT MIXTURE
WO2002035228A3 (en) Method and test kit for detecting analytes in a sample
SE9502024D0 (en) Pathogen assay method
AU2001276703A1 (en) Method of pretreating sample
WO2002048398A3 (en) In situ hybridization system for specifically detecting microorganisms
DK1057021T3 (en) Method for measuring total analyte
AU6379598A (en) Dry analytical elements for the determination of protein
CA2350355A1 (en) Container for holding biologic fluid for analysis
NO20022759L (en) Device for analytical determinations
WO2001010897A3 (en) Methods and compositions for detecting larval taenia solium

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997919087

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 517208

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09180854

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1997919087

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997919087

Country of ref document: EP